Lv3
370 积分 2025-06-05 加入
The Structural Basis for Recognition of Human Leukocyte Antigen Class I Molecules by the Pan-HLA Antibody W6/32
5天前
已完结
The Structural Basis for Recognition of Human Leukocyte Antigen Class I Molecules by the Pan-HLA Antibody W6/32
5天前
已完结
EGFR signaling pathway as therapeutic target in human cancers
2个月前
已完结
Cadonilimab plus platinum-based chemotherapy with or without bevacizumab as first-line treatment for persistent, recurrent, or metastatic cervical cancer (COMPASSION-16): a randomised, double-blind, placebo-controlled phase 3 trial in China
7个月前
已完结
Cadonilimab: First Approval
7个月前
已完结
Enlonstobart: First Approval
7个月前
已完结
Antibody-drug conjugates: A review of cutaneous adverse effects
9个月前
已完结
皖公网安备34019202002308
